It isn't delayed, as per one of their recent announcements it was always due to be released later in the year.
Positives are good in this one - currently at float price, good buy-in. Should run to 30cents in the coming weeks, based on it being:
- tightly held
- Solid product to support global demand.
- Other companies globally who are of the same calibre and stage are much higher in share-price.
- Overall all is well with this one for a medium to long-term play.
scoping study delayed??, page-2
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PWN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $24.90M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.9¢ | $5.877K | 653.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 210681 | 0.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 5628270 | 7 |
View Market Depth
| Last trade - 12.43pm 06/09/2024 (20 minute delay) ? |
| PWN (ASX) Chart |